Baseimmune Secures £9M in Series A to Propel AI-Driven Vaccine Development Against Major Diseases.

Baseimmune is leveraging AI for vaccine development.

Company Name: Baseimmune
Location: London, UK
Sector: Biotechnology / AI-Powered Vaccine Design
Funding Details: Raised £9M in Series A funding, led by MSD Global Health Innovation Fund and IQ Capital, with participation from Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc.
Purpose of Investment: To accelerate the development of vaccine candidates for African swine fever, coronavirus, and malaria, enhance technology, expand the team, and speed up new vaccine programs.

Leadership: Co-founders Joshua Blight and Ariane Gomes
Product: An AI-powered vaccine design algorithm that integrates various data types to create synthetic proteins for inducing protective immune responses. This approach aims to develop cross-protective, “future-proof” vaccines compatible with multiple technology platforms.

About Company: Baseimmune is leveraging AI for vaccine development. Its platform analyzes a vast array of data to predict future pathogen mutations, enabling the creation of novel vaccines designed to protect against both current and emergent strains.

Pelotero Secures $3M in Seed Funding for AI-Powered Player Intelligence Platform

Pelotero is pioneering the integration of AI with sports coaching to create personalized training experiences.

Brenig Therapeutics Secures $65M in Series A Funding for Neurology Drug Development

Brenig Therapeutics is a neurology-focused drug development company utilizing an AI/ML-based discovery platform,

Monarch Tractor Secures $133M in Series C Funding for AI-Driven Agricultural Expansion

Monarch Tractor is pioneering the transformation of the agricultural industry by integrating AI and autonomous technology into its electric vehicle solutions, thus enhancing farm management and sustainability practices globally.

Read next